Fatty Liver During Pregnancy May Elevate Risk of Preterm Birth
Pregnant women with fatty liver disease face a significantly higher risk of preterm birth, highlighting the need for careful monitoring and management during pregnancy.
Recent research highlights a concerning association between metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease, and adverse pregnancy outcomes. A study conducted by Karolinska Institutet analyzed Swedish registry data, revealing that pregnant women with MASLD face a more than threefold increased risk of delivering prematurely. Notably, this elevated risk persists regardless of the severity of liver disease and is independent of obesity, indicating that MASLD itself may directly impact pregnancy.
MASLD affects approximately 20% of the Swedish population and up to 30% globally, predominantly among individuals with metabolic disorders such as type 2 diabetes and obesity. The increasing prevalence among women of reproductive age has prompted investigations into its implications during pregnancy.
The study compared 240 births from women diagnosed with MASLD to 1,140 births from women in the general population, revealing a significant increase in preterm deliveries among those with MASLD. Lead researcher Carole A. Marxer emphasized that this suggests a direct influence of liver disease beyond BMI, urging healthcare providers to monitor pregnant women with MASLD closely to mitigate risks.
In addition to preterm birth, women with MASLD exhibited a 63% higher likelihood of cesarean sections; however, this risk was linked to high BMI rather than MASLD itself. Importantly, the study found no increased risk of congenital malformations or infant mortality associated with MASLD.
The findings underscore the importance of early diagnosis and tailored management strategies for pregnant women with MASLD. Further research is needed to understand the underlying mechanisms and to develop specific clinical guidelines for this growing patient population.
Source: https://medicalxpress.com/news/2025-05-fatty-liver-pregnancy-preterm-birth.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Research Reveals Insufficient Evidence Supporting Air-Cleaning Technologies for Respiratory Infection Prevention
A new study reveals significant gaps in scientific evidence supporting the effectiveness and safety of indoor air-cleaning technologies aimed at preventing respiratory infections like COVID-19 and the flu. Experts call for more real-world research and safety evaluations to guide public health measures.
GLP-1 Medications May Offer Superior Protection Against Dementia Compared to Metformin
Emerging research suggests that GLP-1 receptor agonists may offer enhanced neuroprotective effects over metformin, reducing the risk of dementia in individuals with type 2 diabetes. Discover the latest findings and potential implications for future treatment strategies.
Innovative Imaging Technique Identifies Multiple Subtypes of Triple-Negative Breast Cancer
A novel imaging strategy targeting the tumor microenvironment enhances detection of diverse triple-negative breast cancer subtypes, supporting better diagnosis and personalized treatment planning.
TMEM63A Gene and Its Role in Brain Myelin Formation in Leukodystrophy
Researchers at Oregon Health & Science University have identified the TMEM63A gene as a key regulator of myelin formation in the brain, offering new insights into rare leukodystrophies and potential treatments for demyelinating diseases like multiple sclerosis.